ACUTE GRAFT VERSUS HOST DISEASE
Clinical trials for ACUTE GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new ACUTE GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for ACUTE GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental stem cell therapy tested for deadly transplant complication
Disease control CompletedThis early-stage study tested the safety of stem cells from umbilical cords for treating severe graft-versus-host disease (GVHD), a dangerous complication that can occur after a bone marrow transplant. The study involved 24 adults who developed severe GVHD that didn't respond to …
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE1 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
Stem cell breakthrough tested for deadly transplant complication
Disease control CompletedThis study tested whether adding umbilical cord stem cells to standard steroid treatment helps patients with acute graft-versus-host disease (GVHD), a serious complication that can occur after a bone marrow transplant. The trial involved 26 patients who developed moderate to seve…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Cytopeutics Sdn. Bhd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Diabetes pill may shield transplant patients from deadly immune attack
Prevention CompletedThis study tested if adding the diabetes medication sitagliptin to standard preventive drugs could better protect patients from a dangerous immune reaction called graft-versus-host disease (GVHD) after a stem cell transplant. It involved 190 adults with blood cancers who received…
Matched conditions: ACUTE GRAFT VERSUS HOST DISEASE
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Mar 30, 2026 14:32 UTC